In silico molecular cytogenetics: A bioinformatic approach to prioritization of candidate genes and copy number variations for basic and clinical genome research

Molecular Cytogenetics

Volumn 7, Issue 1, 2014, Pages

  Iourov, Ivan Y ^a,b,c   Vorsanova, Svetlana G ^a,b   Yurov, Yuri B ^a,b  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c Russian Medical Academy of Postgraduate Education   (Russian Federation)

Author keywords

Bioinformatics; Candidate genes; Chromosome imbalances; Copy number variation; Gene expression; Molecular cytogenetics; Somatic mosacism

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; HIGH MOBILITY GROUP N1 PROTEIN; PROTEIN S100B; SUMO 3 PROTEIN;

ANEUPLOIDY; APP GENE; ARTICLE; ATP5O GENE; BIOINFORMATICS; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER MODEL; CONTROLLED STUDY; COPY NUMBER VARIATION; CXADR GENE; CYTOGENETICS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FLUORESCENCE IN SITU HYBRIDIZATION; GABPA GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOMICS; GENOTYPE PHENOTYPE CORRELATION; HMGN1 GENE; HUMAN; MAJOR CLINICAL STUDY; MOSAICISM; PDXK GENE; PRIORITY JOURNAL; S100B GENE; SON GENE; SUMO3 GENE; SYNJ1 GENE; TIAM1 GENE; TTC3 GENE;

EID: 84941763906     PISSN: None     EISSN: 17558166     Source Type: Journal    
DOI: 10.1186/s13039-014-0098-z     Document Type: Article

References (61)

1. Moreau Y, Tranchevent LC: Computational tools for prioritizing candidate genes: boosting disease gene discovery. Nat Rev Genet 2012, 13:523-536.
2. Gan M, Dou X, Jiang R: From ontology to semantic similarity: calculation of ontology-based semantic similarity. Sci World J 2013, 2013:793091.
3. Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, De Smet F, Tranchevent LC, De Moor B, Marynen P, Hassan B, Carmeliet P, Moreau Y: Gene prioritization through genomic data fusion. Nat Biotechnol 2006, 24:537-544.
4. Köhler S, Bauer S, Horn D, Robinson PN: Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 2008, 82:949-958.
5. Chen J, Aronow BJ, Jegga AG: Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinforma 2009, 10:73.
6. Kimmel C, Visweswaran S: An algorithm for network-based gene prioritization that encodes knowledge both in nodes and in links. PLoS One 2013, 8:e79564.
7. Iourov IY, Vorsanova SG, Yurov YB: Molecular cytogenetics and cytogenomics of brain diseases. Curr Genomics 2008, 9:452-465.
8. Hehir-Kwa JY, Wieskamp N, Webber C, Pfundt R, Brunner HG, Gilissen C, de Vries BB, Ponting CP, Veltman JA: Accurate distinction of pathogenic from benign CNVs in mental retardation. PLoS Comput Biol 2010, 6:e1000752.
9. Zeng H, Weier JF, Wang M, Kassabian HJ, Polyzos AA, Baumgartner A, O'Brien B, Weier HU: Bioinformatic tools identify chromosome-specific DNA probes and facilitate risk assessment by detecting aneusomies in extra-embryonic tissues. Curr Genomics 2012, 13:438-445.
10. Iourov IY, Vorsanova SG, Yurov YB: Single cell genomics of the brain: focus on neuronal diversity and neuropsychiatric diseases. Curr Genomics 2012, 13:477-488.
11. O'Brien B, Zeng H, Polyzos AA, Lemke KH, Weier JF, Wang M, Zitzelsberger HF, Weier HU: Bioinformatics tools allow targeted selection of chromosome enumeration probes and aneuploidy detection. J Histochem Cytochem 2013, 61:134-147.
12. Iourov IY, Vorsanova SG, Yurov YB: Somatic cell genomics of brain disorders: a new opportunity to clarify genetic-environmental interactions. Cytogenet Genome Res 2013, 139:181-188.
13. Xu F, Li L, Schulz VP, Gallagher PG, Xiang B, Zhao H, Li P: Cytogenomic mapping and bioinformatic mining reveal interacting brain expressed genes for intellectual disability. Mol Cytogenet 2014, 7:4.
14. Iourov IY, Vorsanova SG, Liehr T, Kolotii AD, Yurov YB: Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain. Hum Mol Genet 2009, 18:2656-2669.
15. Iourov IY, Vorsanova SG, Saprina EA, Yurov YB: Identification of candidate genes of autism on the basis of molecular cytogenetic and in silico studies of the genome organization of chromosomal regions involved in unbalanced rearrangements. Russ J Genet 2010, 46:1190-1193.
16. Iourov IY, Vorsanova SG, Kurinnaia OS, Zelenova MA, Silvanovich AP, Yurov YB: Molecular karyotyping by array CGH in a Russian cohort of children with intellectual disability, autism, epilepsy and congenital anomalies. Mol Cytogenet 2012, 5:46.
17. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW 3rd, Su AI: BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 2009, 10:R130.
18. Iourov IY, Vorsanova SG, Yurov YB: Chromosomal variation in mammalian neuronal cells: known facts and attractive hypotheses. Int Rev Cytol 2006, 249:143-191.
19. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537.
20. Oliver KL, Lukic V, Thorne NP, Berkovic SF, Scheffer IE, Bahlo M: Harnessing gene expression networks to prioritize candidate epileptic encephalopathy genes. PLoS One 2014, 9:e102079.
21. Paratore S, Pezzino S, Cavallaro S: Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways. Curr Genomics 2012, 13:321-333.
22. Chen Y, Wang W, Zhou Y, Shields R, Chanda SK, Elston RC, Li J: In silico gene prioritization by integrating multiple data sources. PLoS One 2011, 6:e21137.
23. Dierssen M, Herault Y, Estivill X: Aneuploidy: from a physiological mechanism of variance to Down syndrome. Physiol Rev 2009, 89:887-920.
24. Vorsanova SG, Iourov IY, Voinova-Ulas VY, Weise A, Monakhov VV, Kolotii AD, Soloviev IV, Novikov PV, Yurov YB, Liehr T: Partial monosomy 7q34-qter and 21pter-q22.13 due to cryptic unbalanced translocation t(7;21) but not monosomy of the whole chromosome 21: a case report plus review of the literature. Mol Cytogenet 2008, 1:13.
25. Van Vooren S, Coessens B, De Moor B, Moreau Y, Vermeesch JR: Array comparative genomic hybridization and computational genome annotation in constitutional cytogenetics: suggesting candidate genes for novel submicroscopic chromosomal imbalance syndromes. Genet Med 2007, 9:642-649.
26. Giglio S, Broman KW, Matsumoto N, Calvari V, Gimelli G, Neumann T, Ohashi H, Voullaire L, Larizza D, Giorda R, Weber JL, Ledbetter DH, Zuffardi O: Olfactory receptor-gene clusters, genomic-inversion polymorphisms, and common chromosome rearrangements. Am J Hum Genet 2001, 68:874-883.
27. Zhou W, Zhang F, Chen X, Shen Y, Lupski JR, Jin L: Increased genome instability in human DNA segments with self-chains: homology-induced structural variations via replicative mechanisms. Hum Mol Genet 2013, 22:2642-2651.
28. Vorsanova SG, Yurov YB, Soloviev IV, Iourov IY: Molecular cytogenetic diagnosis and somatic genome variations. Curr Genomics 2010, 11:440-446.
29. Hoischen A, Krumm N, Eichler EE: Prioritization of neurodevelopmental disease genes by discovery of new mutations. Nat Neurosci 2014, 17:764-772.
30. Yurov YB, Vorsanova SG, Iourov IY: GIN'n'CIN hypothesis of brain aging: deciphering the role of somatic genetic instabilities and neural aneuploidy during ontogeny. Mol Cytogenet 2009, 2:23.
31. Yurov YB, Vorsanova SG, Iourov IY: The DNA replication stress hypothesis of Alzheimer's disease. Sci World J 2011, 11:2602-2612.
32. Li W, Mills AA: Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes. Epigenomics 2014, 6:381-395.
33. Iourov IY, Vorsanova SG, Yurov YB: Somatic genome variations in health and disease. Curr Genomics 2010, 11:387-396.
34. Oromendia AB, Amon A: Aneuploidy: implications for protein homeostasis and disease. Dis Model Mech 2014, 7:15-20.
35. Varetti G, Pellman D, Gordon DJ: Aurea mediocritas: the importance of a balanced genome. Cold Spring Harb Perspect Biol 2014, 6(11).
36. Valind A, Jin Y, Gisselsson D: Elevated tolerance to aneuploidy in cancer cells: estimating the fitness effects of chromosome number alterations by in silico modelling of somatic genome evolution. PLoS One 2013, 8:e70445.
37. Iourov IY, Vorsanova SG, Liehr T, Yurov YB: Aneuploidy in the normal, Alzheimer's disease and ataxia-telangiectasia brain: differential expression and pathological meaning. Neurobiol Dis 2009, 34:212-220.
38. Heng HH, Liu G, Stevens JB, Bremer SW, Ye KJ, Abdallah BY, Horne SD, Ye CJ: Decoding the genome beyond sequencing: the new phase of genomic research. Genomics 2011, 98:242-252.
39. Iourov IY, Vorsanova SG, Yurov YB: Chromosomal mosaicism goes global. Mol Cytogenet 2008, 1:26.
40. Dumanski JP, Piotrowski A: Structural genetic variation in the context of somatic mosaicism. Methods Mol Biol 2012, 838:249-272.
41. Campbell IM, Yuan B, Robberecht C, Pfundt R, Szafranski P, McEntagart ME, Nagamani SC, Erez A, Bartnik M, Wis̈niowiecka-Kowalnik B, Plunkett KS, Pursley AN, Kang SH, Bi W, Lalani SR, Bacino CA, Vast M, Marks K, Patton M, Olofsson P, Patel A, Veltman JA, Cheung SW, Shaw CA, Vissers LE, Vermeesch JR, Lupski JR, Stankiewicz P: Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am J Hum Genet 2014, 95:173-182.
42. Yurov YB, Vostrikov VM, Vorsanova SG, Monakhov VV, Iourov IY: Multicolor fluorescent in situ hybridization on post-mortem brain in schizophrenia as an approach for identification of low-level chromosomal aneuploidy in neuropsychiatric diseases. Brain Dev 2001, 23(Suppl. 1):S186-S190.
43. McConnell MJ, Kaushal D, Yang AH, Kingsbury MA, Rehen SK, Treuner K, Helton R, Annas EG, Chun J, Barlow C: Failed clearance of aneuploid embryonic neural progenitor cells leads to excess aneuploidy in the Atm-deficient but not the Trp53-deficient adult cerebral cortex. J Neurosci 2004, 24:8090-8096.
44. Yurov YB, Vorsanova SG, Iourov IY, Demidova IA, Beresheva AK, Kravetz VS, Monakhov VV, Kolotii AD, Voinova-Ulas VY, Gorbachevskaya NL: Unexplained autism is frequently associated with low-level mosaic aneuploidy. J Med Genet 2007, 44:521-525.
45. Yurov YB, Iourov IY, Vorsanova SG, Demidova IA, Kravetz VS, Beresheva AK, Kolotii AD, Monakchov VV, Uranova NA, Vostrikov VM, Soloviev IV, Liehr T: The schizophrenia brain exhibits low-level aneuploidy involving chromosome 1. Schizophr Res 2008, 98:139-147.
46. Devalle S, Sartore RC, Paulsen BS, Borges HL, Martins RA, Rehen SK: Implications of aneuploidy for stem cell biology and brain therapeutics. Front Cell Neurosci 2012, 6:36.
47. Bushman DM, Chun J: The genomically mosaic brain: aneuploidy and more in neural diversity and disease. Semin Cell Dev Biol 2013, 24:357-369.
48. Yurov YB, Vorsanova SG, Liehr T, Kolotii AD, Iourov IY: X chromosome aneuploidy in the Alzheimer's disease brain. Mol Cytogenet 2014, 7:20.
49. Ulrich H, Bocsi J, Glaser T, Tárnok A: Cytometry in the brain: studying differentiation to diagnostic applications in brain disease and regeneration therapy. Cell Prolif 2014, 47:12-19.
50. Iourov IY, Vorsanova SG, Yurov YB: Recent patents on molecular cytogenetics. Recent Pat DNA Gene Seq 2008, 2:6-15.
51. Vorsanova SG, Yurov YB, Iourov IY: Human interphase chromosomes: a review of available molecular cytogenetic technologies. Mol Cytogenet 2010, 3:1.
52. Yurov YB, Vorsanova SG, Iourov IY: Human Interphase Chromosomes: Biomedical Aspects. Springer; 2013.
53. Vidal M, Cusick ME, Barabási AL: Interactome networks and human disease. Cell 2011, 144:986-998.
54. Haider S, Pal R: Integrated analysis of transcriptomic and proteomic data. Curr Genomics 2013, 14:91-110.
55. Carter H, Hofree M, Ideker T: Genotype to phenotype via network analysis. Curr Opin Genet Dev 2013, 23:611-621.
56. Iourov IY, Vorsanova SG, Voinova VY, Kurinnaia OS, Zelenova MA, Demidova IA, Yurov YB: Xq28 (MECP2) microdeletions are common in mutation-negative females with Rett syndrome and cause mild subtypes of the disease. Mol Cytogenet 2013, 6:53.
57. Vorsanova SG, Iourov IY, Beresheva AK, Demidova IA, Monakhov VV, Kravets VS, Bartseva OB, Goyko EA, Soloviev IV, Yurov YB: Non-disjunction of chromosome 21, alphoid DNA variation, a nd sociogenetic features of Down syndrome. Tsitol Genet 2005, 39(6):30-36.
58. Iourov IY, Vorsanova SG, Pellestor F, Yurov YB: Brain tissue preparations for chromosomal PRINS labeling. Methods Mol Biol 2006, 334:123-132.
59. Shlomi T, Cabili MN, Herrgård MJ, Palsson BØ, Ruppin E: Network-based prediction of human tissue-specific metabolism. Nat Biotechnol 2008, 26:1003-1010.
60. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T: Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011, 27:431-432.
61. Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, Caudy M, Garapati P, Gillespie M, Kamdar MR, Jassal B, Jupe S, Matthews L, May B, Palatnik S, Rothfels K, Shamovsky V, Song H, Williams M, Birney E, Hermjakob H, Stein L, D'Eustachio P: The Reactome pathway knowledgebase. Nucleic Acids Res 2014, 42(Database issue):D472-D477.